DCBLD2 Rekombinanter Antikörper

DCBLD2 Rekombinant Antikörper für WB, IHC, IP, Indirect ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human

Anwendung

WB, IHC, IP, Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

242604E8

Kat-Nr. : 85000-4-PBS

Synonyme

242604E8, CLCP1, CUB, LCCL and coagulation factor V/VIII-homology domains protein 1, Discoidin, CUB and LCCL domain-containing protein 2, Endothelial and smooth muscle cell-derived neuropilin-like protein



Geprüfte Anwendungen

Produktinformation

85000-4-PBS bindet in WB, IHC, IP, Indirect ELISA DCBLD2 und zeigt Reaktivität mit human

Getestete Reaktivität human
Wirt / Isotyp Kaninchen / IgG
Klonalität Rekombinant
Typ Antikörper
Immunogen DCBLD2 fusion protein Ag32823
Vollständiger Name discoidin, CUB and LCCL domain containing 2
Berechnetes Molekulargewicht 775 aa, 89 kDa
Beobachtetes Molekulargewicht120 kDa
GenBank-ZugangsnummerBC029658
Gene symbol DCBLD2
Gene ID (NCBI) 131566
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein A purfication
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

DCBLD2, also known as ESDN or CLCP1, was first identified from human coronary arterial cells by a signal sequence trap method. DCBLD2 regulates proliferation, migration, and invasion in various tumors, including glioma, hypopharyngeal squamous cell carcinoma, and myxofibrosarcoma. The human DCBLD2 protein has a predicted molecular mass of ∼80 kDa based on its amino acid sequence, although it regularly displays an effective molecular mass of ∼130 kDa via SDS-PAGE (PMID: 30902898).